If you’re referring to a recent headline claiming that blood-pressure medication is “under review” because of new heart-risk findings, I’d be cautious with that wording.
Recent 2026 evidence has led to changes and refinements in how hypertension is treated, but it does not mean that common blood-pressure medicines have suddenly been found to be dangerous or should generally be stopped. The 2025 AHA/ACC guideline continues to recommend medication when appropriate, alongside lifestyle measures, and emphasizes cardiovascular-risk assessment.
A
American Heart Association
+1
One notable 2026 development concerns beta-blockers after a heart attack: a trial found that some stable, relatively low-risk patients who had been taking beta-blockers for at least a year could discontinue them without a higher risk of death, recurrent heart attack, or heart-failure hospitalization. That finding applies to a specific group, not everyone taking a beta-blocker for hypertension.
A
American College of Cardiology
Don’t stop or change your blood-pressure medication based on a headline. The right decision depends on the particular drug, dose, reason you’re taking it, blood-pressure readings, kidney function, and cardiovascular history.
If you give me the name of the blood-pressure medication (for example, amlodipine, losartan, lisinopril, hydrochlorothiazide, or a beta-blocker), I can check the latest evidence and tell you exactly what the new findings mean for that drug.
A
A
Sources
